SP100030 is a novel T-cell-specific transcription factor inhibitor that possesses immunosuppressive activity in vivo (Q71878966)
Jump to navigation
Jump to search
scientific article published on 01 December 1996
Language | Label | Description | Also known as |
---|---|---|---|
English | SP100030 is a novel T-cell-specific transcription factor inhibitor that possesses immunosuppressive activity in vivo |
scientific article published on 01 December 1996 |
Statements
SP100030 is a novel T-cell-specific transcription factor inhibitor that possesses immunosuppressive activity in vivo (English)
Goldman ME
Ransone LJ
Anderson DW
Gaarde WA
Suto MJ
Sullivan RW
Shorthouse R
Morikawa M
1 December 1996